-
00:29
1.
index 1
-
00:00
2.
Introduction
-
00:13
3.
Breast cancer (BC)
-
00:05
4.
Subtypes of breast cancer:
-
00:25
5.
Breast cancer (BC)
-
00:11
6.
** after 20210427.pptx
-
00:43
7.
Subtypes of breast cancer:
-
00:51
8.
Treatments of breast cancer
-
00:49
9.
Chemotherapy of triple-negative breast cancer
-
00:57
10.
Long non-coding RNA (lnc RNA)
-
00:39
11.
Myc
-
00:15
12.
Aim of this study
-
00:01
13.
Slide 10
-
01:04
14.
Identification of lncRNAs differentially expressed in breast cancer
-
00:00
15.
Slide 10
-
00:00
16.
Aim of this study
-
00:00
17.
Myc
-
00:01
18.
Long non-coding RNA (lnc RNA)
-
00:04
19.
Chemotherapy of triple-negative breast cancer
-
00:01
20.
Long non-coding RNA (lnc RNA)
-
00:00
21.
Myc
-
00:00
22.
Aim of this study
-
00:00
23.
Slide 10
-
01:11
24.
Identification of lncRNAs differentially expressed in breast cancer
-
00:48
25.
Slide 12
-
00:01
26.
Slide 13
-
00:36
27.
Slide 12
-
00:18
28.
Slide 13
-
01:22
29.
Slide 14
-
01:29
30.
Linc00839 knockdown suppressed cell proliferation and increased sensitivity to paclitaxel in vitro.
-
03:01
31.
Slide 16
-
00:05
32.
Slide 17
-
00:02
33.
Slide 16
-
01:46
34.
Slide 17
-
02:56
35.
Linc00839 knockdown inhibited tumor proliferation in vivo.
-
01:00
36.
Myc activates Linc00839 transcription and regulates its expression level.
-
00:01
37.
Slide 20
-
00:16
38.
Myc activates Linc00839 transcription and regulates its expression level.
-
03:42
39.
Slide 20
-
05:45
40.
Linc00839 regulates Lin28B and Myc mRNA and protein expression.
-
03:11
41.
Slide 22
-
00:00
42.
Slide 23
-
00:49
43.
Slide 22
-
03:00
44.
Slide 23
-
01:55
45.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
-
00:03
46.
Slide 25
-
01:02
47.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
-
01:38
48.
Slide 25
-
02:48
49.
Slide 26
-
00:00
50.
Slide 27
-
00:49
51.
Comment
-
11:26
52.
** after 20210427.pptx
-
00:22
53.
Slide 17